Progressive multifocal leukoencephalopathy in patients with systemic lupus erythematosus: A systematic literature review

Lupus

Volumn 25, Issue 6, 2016, Pages 617-626

  Henegar, Cassidy E ^a   Eudy, A M ^a,b   Kharat, V ^a   Hill, D D ^a   Bennett, D ^a   Haight, B ^a  

^a GLAXOSMITHKLINE   (United States)

^b The University of North Carolina at Chapel Hill   (United States)

Author keywords

immunosuppressant medications; monoclonal antibodies; Progressive multifocal leukoencephalopathy; systemic lupus erythematosus

Indexed keywords

ANTIMALARIAL AGENT; AZATHIOPRINE; BELIMUMAB; CHLOROQUINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DAPSONE; ETANERCEPT; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; LEFLUNOMIDE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; RITUXIMAB; TETRACOSACTIDE; THALIDOMIDE; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; NONHUMAN; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RISK FACTOR; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; ADULT; COMPLICATION; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; LUPUS ERYTHEMATOSUS, SYSTEMIC; PATHOPHYSIOLOGY;

ADULT; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; LUPUS ERYTHEMATOSUS, SYSTEMIC; RISK FACTORS;

EID: 84963626924     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203315622819     Document Type: Article

References (61)

1. Boothpur R, Brennan DC,. Human polyoma viruses and disease with emphasis on clinical BK and JC. J Clin Virol 2010; 47: 306-312.
2. Tan CS, Koralnik IJ, BK, and other polyomaviruses: progressive multifocal leukoencephalopathy. In: Mandell GL, (ed). Principles and practices of infectious diseases, Philadelphia, PA: Churchill Livingstone, 2009, pp. 2051-2058.
3. Astrom KE, Mancall EL, Richardson EP Jr,. Progressive multifocal leukoencephalopahty: a hitherto unrecognized complication of chronic lymphocytic leukaemia and Hodgkins disease. Brain 1958; 81: 93-111.
4. Egli A, Infanti L, Dumoulin A, et al. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis 2009; 199: 837-846.
5. Engels EA, Rollison DE, Hartge P, et al. Antibodies to JC and BK viruses among persons with non-Hodgkin lymphoma. Int J Cancer 2005; 117: 1013-1019.
6. Knowles WA, Pipkin P, Andrews N, et al. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol 2003; 71: 115-123.
7. Vanchiere JA, Human polyomaviruses. In: Feigin RD, (ed). Feigin and Cherry's textbook of pediatric infectious diseases, Philadelphia, PA: Saunders/Elsevier, 2009, pp. 1863-1870.
8. Elphick GF, Querbes W, Jordan JA, et al. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 2004; 306: 1380-1383.
9. Koralnik IJ,. New insights into progressive multifocal leukoencephalopathy. Curr Opin Neurol 2004; 17: 365-370.
10. Engsig FN, Hansen AB, Omland LH, et al. Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study. J Infect Dis 2009; 199: 77-83.
11. Arkema EV, van Vollenhoven RF, Askling J, ARTIS Study Group. Incidence of progressive multifocal leukoencephalopathy in patients with rheumatoid arthritis: a national population-based study. Ann Rheum Dis 2012; 71: 1865-1867.
12. Coloma PM. Mining electronic healthcare record databases to augment drug safety surveillance. PhD Dissertation, Erasmus MC University Medical Center, The Netherlands, 2012.
13. Molloy ES, Calabrese LH,. Progressive multifocal leukoencephalopathy: A national estimate in systemic lupus erythematosus and other rheumatic diseases. Arthritis Rheum 2009; 60: 3761-3765.
14. Toloza SM, Roseman JM, Alarcon GS, et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXII. Predictors of time to the occurrence of initial damage. Arthritis Rheum 2004; 50: 3177-3186.
15. Urowitz MB, Gladman DD,. How to improve morbidity and mortality in systemic lupus erythematosus. Rheumatol 2000; 39: 238-244.
16. Van Vollenhoven RF, Jacobsen S, Wallace D, et al. Biologics use in SLE in 23 centers: Data from the international registry for biologics in SLE. Ann Rheum Dis 2012; 71: A9.
17. Molloy ES, Calabrese LH,. Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: Are patients with systemic lupus erythematosus at particular risk? Autoimmun Rev 2008; 8: 144-146.
18. Berger JR, Aksamit AS, Clifford DB, et al. PML diagnostic criteria: consensus statement from the AAN Neurosciences Disease Section. Neurology 2013; 80: 1430-1438.
19. Amend KL, Turnbull B, Foskett N, et al. Incidence of progressive multifocal leukoencephalopathy in patients without HIV. Neurology 2010; 75: 1326-1332.
20. Foskett N, Huang K, Petri H, et al. Incidence of progressive multifocal leukoencephalopathy (PML) in patients with rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE) from MarketScan Claim Database. Pharmacoepidemiol Drug Saf 2009; 18: S40-S41.
21. Martins C, Guedes C, Goncalves A, et al. Opportunistic infections in a cohort of systemic lupus erythematosus. Lupus 2011; 20: 105.
22. Molloy ES, Calabrese LH,. Progressive multifocal encephalopathy associated with immunosuppressive therapy in rheumatic diseases: evolving role of biologic therapies. Arthritis Rheum 2012; 64: 3043-3051.
23. Carson KR, Evens AM, Richey EA, et al. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood 2009; 113: 4834-4840.
24. Damasio J, Brandao M, Marinho A, et al. Progressive multifocal leukoencephalopathy in lupus. Lupus 2011; 20: 126.
25. Fredericks CA, Kvam KA, Bear J, Crabtree GS, Josephson SA,. A case of progressive multifocal leukoencephalopathy in a lupus patient treated with belimumab. Lupus 2014; 23: 711-713.
26. Ahmed F, Aziz T, Kaufman LD,. Progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus. J Rheumatol 1999; 26: 1609-1612.
27. Akahoshi T, Ishikawa M, Takahashi M, et al. A case of systemic lupus erythematosus complicated by progressive multifocal leukoencephalopathy: case report and review of the literature. Japan J Rhematol 1997; 7: 55-60.
28. Beppu M, Kawamoto M, Nukuzuma S, Kohara N,. Mefloquine improved progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus. Intern Med 2012; 51: 1245-1247.
29. Brandao M, Damasio J, Marinho A, et al. Systemic lupus erythematosus, progressive multifocal leukoencephalopathy, and T-CD4+ lymphopenia. Clinic Rev Allerg Immunol 2012; 43: 302-307.
30. Calabrese LH, Molloy ES, Huang D, Ransohoff RM,. Progressive multifocal leukoencephalopathy in rheumatic diseases: evolving clinical and pathologic patterns of disease. Arthritis Rheum 2007; 56: 2116-2128.
31. Goncalves FG, Lamb L, Del Carpio-O'Donovan R,. Progressive multifocal leukoencephalopathy restricted to the posterior fossa in a patient with systemic lupus erythematosus. Braz J Infect Dis 2011; 15: 609-612.
32. Govindappa V, Hicks S, Wichter M, Jolly M,. Progressive multifocal leukoencephalopathy in systemic lupus erythematosus. Arthritis Rheum 2007; 52: 352-354.
33. Graff-Radford J, Robinson MT, Warsame RM, Matteson EL, Eggers SDZ, Keegan BM,. Progressive multifocal leukoencephalopathy in a patient treated with etanercept. Neurologist 2012; 18: 85-87.
34. Harris HE,. Progressive multifocal leucoencephalopathy in a patient with systemic lupus erythematosus treated with rituximab. Rheumatology 2008; 47: 225-226.
35. Itoh K, Kano T, Nagashio C, Mimori A, Kinoshita M, Sumiya M,. Progressive multifocal leukoencephalopathy in patients with systemic lupus erythematosus. Arthritis Rheum 2006; 54: 1020-1025.
36. Kinoshita M, Iwana K, Shinoura H, Aotsuka S, Sumiya M,. Progressive multifocal leukoencephalopathy resembling central nervous system lupus erythematosus. Clin Exp Rheumatol 1998; 16: 313-315.
37. Krupp LB, Lipton RB, Swerdlow ML, Leeds NE, Llena J,. Progressive multifocal leukoencephalopathy: clinical and radiographic features. Ann Neurol 1985; 17: 344-349.
38. Lefevre G, Queyrel V, Maurage CA, et al. Effective immune restoration after immunosuppressant discontinuation in a lupus patient presenting progressive multifocal leukoencephalopathy. J Neurological Sci 2009; 287: 246-249.
39. Medin K, Coyle P, Seidman R, Al-Mufti F, Kim B,. Inflammatory variant of progressive multifocal leukoencephalopathy; in a patient with early systemic lupus erythematosus. Neurology 2012; 78. (abstract P07.055).
40. Newton P, Aldridge RD, Lessells AM, Best PV,. Progressive multifocal leukoencephalopathy complicating systemic lupus erythematosus. Arthritis Rheum 1986; 29: 337-343.
41. Nived O, Bengtsson AA, Jonsen A, Sturfelt G,. Progressive multifocal leukoencephalopathy-the importance of early diagnosis illustrated in four cases. Lupus 2008; 17: 1036-1041.
42. Pavlovic AM, Bonaci-Nikolic B, Kozic D, et al. Progressive multifocal leukoencephalopathy associated with mycophenolate mofetil treatment in a woman with lupus and CD4+ T-lymphocyte deficiency. Lupus 2012; 21: 100-102.
43. Reilmann R, Imai T, Ringelstein EB, et al. Remission of progressive multifocal leucoencephalopathy in SLE after treatment with cidofovir: a 4 year follow up. J Neurol Neurosurg Psychiatry 2005; 76: 1304-1312.
44. Roberts JR, Finger DR,. Progressive multifocal leukoencephalopathy mimicking central nervous system lupus. J Rheumatol 2007; 34: 2119-2120.
45. Salmaggi A, Maccagnano E, Castagna A, et al. Reversal of CSF positivity for JC virus genome by cidofovir in a patient with systemic lupus erythematosus and progressive multifocal leukoencephalopathy. Neurol Sci 2001; 22: 17-20.
46. Shprecher D, Frech T, Chin S, Eskandari R, Steffens J,. Progressive multifocal leucoencephalopathy associated with lupus and methotrexate overdose. Lupus 2008; 17: 1029-1032.
47. Stahl NI,. Progressive multifocal leukoencephalopathy in a minimally immunosuppressed patient with systemic lupus erythematosus treated with dapsone. J Rheumatol 2008; 35: 725-727.
48. Svensson PA, Larsson EM,. Infratentorial progressive multifocal leucoencephalopathy (PML) in a patient with SLE. Eur Radiol 2008; 18: 1526-1528.
49. Vanecasteele SJ, Maes B, Claes K, Sciot R, Vanrenterghem Y,. High anti-double-stranded DNA antibodies and progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus. Nephrol Dial Transplant 2005; 20: 1246-1247.
50. Vollmer-Haase J, Young P, Ringelstein EB,. Efficacy of camptothecin in progressive multifocal leucoencephalopathy. Lancet 1997; 349: 1366.
51. Warnatz K, Peter HH, Schumacher M, et al. Infectious CNS disease as a differential diagnosis in systemic rheumatic diseases: three case reports and a review of the literature. Ann Rheum Dis 2003; 62: 50-57.
52. White RP, Abraham S, Singhal S, Manji H, Clarke CRA,. Progressive multifocal leucoencephalopathy isolated to the posterior fossa in a patient with systemic lupus erythematosus. Rheumatology 2002; 41: 826-827.
53. Leblanc-Trudeau C, Masetto A, Bocti C,. Progressive multifocal leukoencephalopathy associated with belimumab in a patient with systemic lupus erythematosus. J Rheumatol 2015; 42: 551-552.
54. Schmedt N, Andersohn F, Garbe E,. Signals of progressive multifocal leukoencephalopathy for immunosuppressants: a disproportionality analysis of spontaneous reports within the US Adverse Event Reporting System (AERS). Pharmacoepidemiol Drug Saf 2012; 21: 1216-1220.
55. Calabrese LH, Molloy E, Berger J,. Sorting out the risks in progressive multifocal leukoencephalopathy. Nat Rev Rheumatol 2015; 11: 119-123.
56. Calabrese LH, Molloy ES,. Progressive multifocal leucoencephalopathy in the rheumatic diseases: Assessing the risks of biological immunosuppressive therapies. Ann Rheum Dis 2008; 67: iii64-iii65.
57. Pyrpasopoulou A, Chatzimichailidou S, Aslanidis S. Vascular disease in systemic lupus erythematosus. Autoimmune Dis, Epub, DOI: 10.1155/2012/876456.
58. Durali D, de Goër de Herve M-G, Gasnault J, Taoufik Y,. B cells and progressive multifocal leukoencephalopathy: search for the missing link. Front Immunol 2015; 6. article 241. doi:10.3389/fimmu.2015.00241.
59. Pagnoux C, Hayem G, Roux F, et al. JC virus leukoencephalopathy complicating Wegener's granulomatosis. Joint Bone Spine 2003; 70: 376-379.
60. Thamer M, Hernan MA, Zhang YI, Cotter D, Petri M,. Prednisone, lupus activity, and permanent organ damage. J Rheumatol 2009; 36: 560-564.
61. Zahr ZA, Fang H, Magder L, Petri M,. Predictors of corticosteroid tapering in SLE patients: the Hopkins Lupus Cohort. Lupus 2013; 22: 697-701.